Doloromics evensions a world without pain where precision medicines alleviate human suffering.
Our team of the world's leading pain experts is developing novel therapeutics using our proprietary platform that is built on a foundation of datasets of human neuronal tissues.
Effective treatments for pain are not making it to patients that suffer because therapeutics are failing to target underlying mechanisms.
Using a human-first approach, Doloromics has built a proprietary computational and human cell-based platform, DOLOReS, to identify targets and develop precision therapeutics that target pain at the source.